10-Q
Quarterly Report
Autonomix Medical, Inc.
AMIX
NASDAQ
CIK: 1617867
File #: 001-41940
Balance Sheet
28 line items · 2 periods
XBRL
| Item | Dec 31, 2024 | Mar 31, 2024 |
|---|---|---|
Current assets: | ||
Cash and cash equivalents | 11,823,000 | 8,608,000 |
Other current assets | 109,000 | 783,000 |
Total current assets | 11,932,000 | 9,391,000 |
Long term assets: | ||
Fixed assets, net | 20,000 | 16,000 |
Total long term assets | 20,000 | 16,000 |
Total Assets | 11,952,000 | 9,407,000 |
Current liabilities: | ||
Accounts payable | 232,000 | 492,000 |
Short term debt - convertible notes, net of unamortized debt discount | 1,132,000 | 0 |
Accrued expenses | 881,000 | 285,000 |
Total current liabilities | 2,245,000 | 777,000 |
Long term liabilities: | ||
Long term debt - convertible notes, net of unamortized debt discount | 0 | 1,002,000 |
The Notes - Convertible Debt | 1,132,000 | — |
Total long term liabilities | 0 | 1,002,000 |
Total Liabilities | 2,245,000 | 1,779,000 |
Stockholders' equity: | ||
Preferred stock, $0.001 par value, 10,000,000 shares authorized, no shares issued and outstanding as of December 31, 2024 and March 31, 2024, respectively | 0 | 0 |
Common stock, $0.001 par value, 500,000,000 shares authorized, 2,462,983 and 942,575 shares issued and outstanding as of December 31, 2024 and March 31, 2024, respectively | 2,000 | 1,000 |
Additional paid-in capital | 56,892,000 | 46,596,000 |
Accumulated deficit | (47,187,000) | (38,969,000) |
Total Stockholders' Equity | 9,707,000 | 7,628,000 |
Common Stock | 2,000 | 1,000 |
Additional Paid-in Capital | 56,892,000 | 46,596,000 |
Retained Earnings | (47,187,000) | (38,969,000) |
Total Liabilities and Stockholders' Equity | 11,952,000 | 9,407,000 |